Variant report

Variant	rs8176497
Chromosome Location	chr2:188354070-188354071
allele	G/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr2:188351514..188353053-chr2:188353863..188355365,2	MCF-7	breast:
2	chr2:188353320..188355812-chr2:188357936..188360335,2	K562	blood:

Extended variants
information (count: 50 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:31)

rs_ID	r²[population]
rs11887657	1.00[JPT][hapmap]
rs12612748	0.87[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs12622831	0.81[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs1861309	0.83[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs3771070	1.00[CEU][hapmap];0.85[JPT][hapmap];0.96[EUR][1000 genomes];0.84[ASN][1000 genomes]
rs3771071	1.00[CEU][hapmap];1.00[JPT][hapmap];0.96[EUR][1000 genomes];0.84[ASN][1000 genomes]
rs3771072	1.00[CEU][hapmap];1.00[JPT][hapmap];0.92[EUR][1000 genomes];0.84[ASN][1000 genomes]
rs6731106	0.96[EUR][1000 genomes];0.84[ASN][1000 genomes]
rs6737903	0.81[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs6760862	0.96[EUR][1000 genomes];0.84[ASN][1000 genomes]
rs73981578	0.96[EUR][1000 genomes];0.84[ASN][1000 genomes]
rs7565807	0.81[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs7595610	1.00[YRI][hapmap]
rs7595810	1.00[CEU][hapmap];1.00[JPT][hapmap];0.87[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs8176418	0.91[YRI][hapmap];0.94[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs8176420	0.83[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs8176430	1.00[YRI][hapmap]
rs8176444	0.83[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs8176482	0.81[AMR][1000 genomes];0.88[EUR][1000 genomes]
rs8176490	0.83[AMR][1000 genomes];0.88[EUR][1000 genomes]
rs8176493	0.82[YRI][hapmap]
rs8176499	1.00[YRI][hapmap]
rs8176565	0.87[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs8176594	0.81[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs8176603	0.81[AMR][1000 genomes];0.88[EUR][1000 genomes]
rs8176606	1.00[CEU][hapmap];1.00[JPT][hapmap];0.81[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs8176608	1.00[CEU][hapmap];1.00[JPT][hapmap];0.81[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs8176611	1.00[CEU][hapmap];1.00[JPT][hapmap];0.81[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs8176616	1.00[CEU][hapmap];1.00[JPT][hapmap];0.81[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs8176622	1.00[CEU][hapmap];1.00[JPT][hapmap];0.81[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs8176625	0.81[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:19 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv949700	chr2:187713412-188361211	Flanking Active TSS Strong transcription Enhancers ZNF genes & repeats Weak transcription Active TSS Bivalent/Poised TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	8 gene(s)	inside rSNPs	diseases
2	nsv875557	chr2:188219052-188370232	Flanking Active TSS Weak transcription Enhancers Strong transcription Active TSS ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	4 gene(s)	inside rSNPs	diseases
3	nsv875558	chr2:188219052-188388311	Enhancers Strong transcription Weak transcription Flanking Active TSS Active TSS ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	4 gene(s)	inside rSNPs	diseases
4	nsv875559	chr2:188219052-188390112	Active TSS ZNF genes & repeats Weak transcription Strong transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	4 gene(s)	inside rSNPs	diseases
5	nsv875560	chr2:188219052-188508011	Weak transcription Strong transcription Enhancers Transcr. at gene 5' and 3' Active TSS Flanking Active TSS Bivalent Enhancer ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	7 gene(s)	inside rSNPs	diseases
6	nsv875561	chr2:188226900-188440752	Weak transcription Flanking Active TSS Enhancers Active TSS Strong transcription Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	4 gene(s)	inside rSNPs	diseases
7	nsv584036	chr2:188256158-188369841	Weak transcription Strong transcription Active TSS Enhancers Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	4 gene(s)	inside rSNPs	diseases
8	nsv875562	chr2:188258904-188370232	Enhancers Weak transcription Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Strong transcription Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	4 gene(s)	inside rSNPs	diseases
9	nsv875563	chr2:188258904-188388311	ZNF genes & repeats Enhancers Weak transcription Strong transcription Active TSS Flanking Active TSS Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	4 gene(s)	inside rSNPs	diseases
10	nsv875564	chr2:188258904-188414161	Weak transcription Strong transcription Enhancers Flanking Active TSS Genic enhancers ZNF genes & repeats Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	4 gene(s)	inside rSNPs	diseases
11	nsv875565	chr2:188258904-188440752	Weak transcription Genic enhancers ZNF genes & repeats Strong transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	4 gene(s)	inside rSNPs	diseases
12	nsv875566	chr2:188258904-188626214	Weak transcription Active TSS Enhancers Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	8 gene(s)	inside rSNPs	diseases
13	nsv875567	chr2:188258904-188673462	Flanking Active TSS ZNF genes & repeats Active TSS Weak transcription Enhancers Strong transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	8 gene(s)	inside rSNPs	diseases
14	nsv834488	chr2:188268434-188415496	Enhancers Strong transcription Active TSS Weak transcription Genic enhancers ZNF genes & repeats Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	4 gene(s)	inside rSNPs	diseases
15	nsv875568	chr2:188291105-188653806	Weak transcription Enhancers Flanking Active TSS Active TSS ZNF genes & repeats Genic enhancers Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	7 gene(s)	inside rSNPs	diseases
16	nsv875572	chr2:188330682-188355835	Flanking Active TSS Strong transcription Weak transcription Enhancers Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Active TSS	Chromatin interactive region lncRNA miRNA target site	n/a	inside rSNPs	diseases
17	nsv875576	chr2:188343497-188482933	Transcr. at gene 5' and 3' Genic enhancers Weak transcription Enhancers ZNF genes & repeats Flanking Active TSS Active TSS Strong transcription Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	5 gene(s)	inside rSNPs	diseases
18	nsv875577	chr2:188343497-188500930	Weak transcription Enhancers Flanking Active TSS Strong transcription Active TSS ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	5 gene(s)	inside rSNPs	diseases
19	nsv875578	chr2:188343497-188690187	Flanking Active TSS Enhancers Genic enhancers Strong transcription Weak transcription ZNF genes & repeats Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	7 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:47 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:188326800-188357600	Weak transcription	Duodenum Mucosa	Duodenum
2	chr2:188326800-188357800	Weak transcription	Lung	lung
3	chr2:188327000-188357800	Weak transcription	Left Ventricle	heart
4	chr2:188327200-188357600	Weak transcription	Fetal Intestine Large	intestine
5	chr2:188328200-188357600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
6	chr2:188328200-188360000	Weak transcription	Psoas Muscle	Psoas
7	chr2:188328400-188365400	Weak transcription	Skeletal Muscle Female	skeletal muscle
8	chr2:188328600-188357200	Weak transcription	Fetal Muscle Trunk	muscle
9	chr2:188329000-188358000	Weak transcription	K562	blood
10	chr2:188332800-188357600	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
11	chr2:188334200-188374600	Weak transcription	Placenta Amnion	Placenta Amnion
12	chr2:188339800-188357600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
13	chr2:188341200-188357200	Weak transcription	Primary hematopoietic stem cells short term culture	blood
14	chr2:188342600-188356600	Weak transcription	HUES64 Cell Line	embryonic stem cell
15	chr2:188342800-188357200	Weak transcription	Primary hematopoietic stem cells	blood
16	chr2:188342800-188362400	Strong transcription	HSMM	muscle
17	chr2:188343800-188357600	Weak transcription	Fetal Muscle Leg	muscle
18	chr2:188347000-188360200	Weak transcription	Rectal Smooth Muscle	rectum
19	chr2:188349000-188357200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
20	chr2:188349000-188361000	Weak transcription	NH-A	brain
21	chr2:188349000-188366600	Weak transcription	Pancreatic Islets	Pancreatic Islet
22	chr2:188349200-188354600	Weak transcription	Liver	Liver
23	chr2:188349200-188356000	Weak transcription	Fetal Lung	lung
24	chr2:188349200-188356400	Weak transcription	A549	lung
25	chr2:188349200-188357800	Weak transcription	HSMMtube	muscle
26	chr2:188349200-188359200	Weak transcription	Hela-S3	cervix
27	chr2:188349600-188355400	Weak transcription	Muscle Satellite Cultured Cells	--
28	chr2:188349600-188357000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
29	chr2:188349600-188357200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
30	chr2:188349600-188359600	Weak transcription	NHLF	lung
31	chr2:188349800-188356000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
32	chr2:188349800-188356400	Weak transcription	Cortex derived primary cultured neurospheres	brain
33	chr2:188349800-188357800	Weak transcription	Placenta	Placenta
34	chr2:188350200-188357800	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
35	chr2:188350600-188370000	Weak transcription	Small Intestine	intestine
36	chr2:188352400-188357600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
37	chr2:188353200-188354600	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
38	chr2:188353400-188354200	Active TSS	Adipose Nuclei	Adipose
39	chr2:188353600-188354200	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
40	chr2:188353600-188354200	Active TSS	Duodenum Smooth Muscle	Duodenum
41	chr2:188353600-188354400	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
42	chr2:188353800-188354200	Flanking Active TSS	Osteobl	bone
43	chr2:188353800-188355000	Transcr. at gene 5' and 3'	HUVEC	blood vessel
44	chr2:188354000-188354200	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
45	chr2:188354000-188354400	Active TSS	NHDF-Ad	bronchial
46	chr2:188354000-188356600	Weak transcription	HepG2	liver
47	chr2:188354000-188358000	Weak transcription	Ovary	ovary

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links